REFERENCES

1. Chen Y, Yang H, Li D, et al. Association of cardiorespiratory fitness with the incidence and progression trajectory of cardiometabolic multimorbidity. Br J Sports Med. 2025;59:306-15.

2. Fan J, Sun Z, Yu C, et al.; China Kadoorie Biobank Collaborative Group. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J. 2022;135:648-57.

3. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575-84.

4. Beard JR, Officer AM, Cassels AK. The World Report on Ageing and Health. Gerontologist. 2016;56 Suppl 2:S163-6.

5. Su B, Liu C, Chen L, Wu Y, Li J, Zheng X. Long-term exposure to PM_2.5 and O₃ with cardiometabolic multimorbidity: evidence among Chinese elderly population from 462 cities. Ecotoxicol Environ Saf. 2023;255:114790.

6. Ding L, Liang Y, Tan ECK, et al. Smoking, heavy drinking, physical inactivity, and obesity among middle-aged and older adults in China: cross-sectional findings from the baseline survey of CHARLS 2011-2012. BMC Public Health. 2020;20:1062.

7. Krentz A, Jacob S, Heiss C, et al.; International Cardiometabolic Working Group. Rising to the challenge of cardio-renal-metabolic disease in the 21st century: translating evidence into best clinical practice to prevent and manage atherosclerosis. Atherosclerosis. 2024;396:118528.

8. He C, Wu F, Fu L, et al. Improving cardiovascular risk prediction with machine learning: a focus on perivascular adipose tissue characteristics. Biomed Eng Online. 2024;23:77.

9. Subramani S, Varshney N, Anand MV, et al. Cardiovascular diseases prediction by machine learning incorporation with deep learning. Front Med. 2023;10:1150933.

10. Krittanawong C, Virk HUH, Bangalore S, et al. Machine learning prediction in cardiovascular diseases: a meta-analysis. Sci Rep. 2020;10:16057.

11. Mao D, Mu J, Li Y, et al. Network-based machine learning reveals cardiometabolic multimorbidity patterns and modifiable lifestyle factors: a community-focused analysis of NHANES 2015-2018. BMC Public Health. 2025;25:2297.

12. Zhu J, Shi Z, Ge Z, et al. Comparative analysis of cardiometabolic multimorbidity predictors in China and the USA: a machine learning approach. Diabetes Res Clin Pract. 2025;229:112938.

13. Mukherjee M, Mukherjee S, Thokala HR, Ali RH. Classifying complex multimorbidity using latent class analysis and machine learning to generate insights into clustering of mental and cardiometabolic conditions. PLoS One. 2025;20:e0335676.

14. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43:61-8.

15. Chen X, Crimmins E, Hu PP, et al. Venous blood-based biomarkers in the China Health and Retirement Longitudinal Study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188:1871-7.

16. Cui Z, Yi X, Huang Y, et al. Effects of socioeconomic status and regional inequality on the association between PM_2.5 and its components and cardiometabolic multimorbidity: a multicenter population-based survey in eastern China. Sci Total Environ. 2024;946:174453.

17. Li D, Lin J, Yang H, et al. Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation. Cardiovasc Diabetol. 2025;24:241.

18. Yin X, Chen Y, Zhou L, Yang H, Wang Y. Association between chronic pain and risk of cardiometabolic multimorbidity: a prospective cohort study. Reg Anesth Pain Med. 2025;50:858-64.

19. Mou P, Qu H, Guan J, Yao Y, Zhang Z, Dong J. Extreme temperature events, functional dependency, and cardiometabolic multimorbidity: Insights from a national cohort study in China. Ecotoxicol Environ Saf. 2024;284:117013.

20. Li J, Lei L, Wang W, et al. Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults. J Am Heart Assoc. 2024;13:e034996.

21. Li D, Wang L, Zhou Z, et al. Role of socioeconomic, lifestyle, and clinical factors in the progression of cardiometabolic multimorbidity in China: a 10-year prospective cohort study. Nutr Metab Cardiovasc Dis. 2022;32:2383-91.

22. Liu J, Liu W, Wang L, et al. Association of visceral adiposity index and handgrip strength with cardiometabolic multimorbidity among middle-aged and older adults: findings from Charls 2011-2020. Nutrients. 2024:16.

23. Sun H, Wu Z, Wang G, Liu J. Normalized creatinine-to-cystatin C ratio and risk of cardiometabolic multimorbidity in middle-aged and older adults: insights from the China Health and Retirement Longitudinal Study. Diabetes Metab J. 2025;49:448-61.

24. Lai H, Tu Y, Liao C, Zhang S, He L, Li J. Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011-2018. Cardiovasc Diabetol. 2025;24:109.

25. He L, Lin C, Tu Y, et al. Correlation of cardiometabolic index and sarcopenia with cardiometabolic multimorbidity in middle-aged and older adult: a prospective study. Front Endocrinol. 2024;15:1387374.

26. Wang K, Adjeroh DA, Fang W, et al. Comparison of deep learning and traditional machine learning models for predicting mild cognitive impairment using plasma proteomic biomarkers. Int J Mol Sci. 2025:26.

27. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18:153-71.

28. Lindsey JK. A review of some extensions to generalized linear models. Stat Med. ;18:2223-36.

29. Rigatti SJ. Random forest. J Insur Med. 2017;47:31-9.

30. Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare. Nat Med. 2019;25:24-9.

31. Miao N, Yang M, Han P, et al. A new ensemble learning method stratified sampling blending optimizes conventional blending and improves prediction performance. Bioinform Adv. 2025;5:vbaf002.

32. Bunkhumpornpat C, Boonchieng E, Chouvatut V, Lipsky D. FLEX-SMOTE: Synthetic over-sampling technique that flexibly adjusts to different minority class distributions. Patterns. 2024;5:101073.

33. Dunias ZS, Van Calster B, Timmerman D, Boulesteix AL, van Smeden M. A comparison of hyperparameter tuning procedures for clinical prediction models: a simulation study. Stat Med. 2024;43:1119-34.

34. Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315-6.

35. Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA. 2017;318:1377-84.

36. Brier GW. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78:1-3.

37. Ruan X, Ling Y, Chen J, et al. Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24:382.

38. Li X, Zhao L, Zhao W, Sun T, Pan H, Wang D. The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and all-cause and cardiovascular mortality in populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study. Am J Nephrol. 2025;:1-15.

39. Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129:343-66.

40. Xu B, Wu Q, La R, et al. Is systemic inflammation a missing link between cardiometabolic index with mortality? Cardiovasc Diabetol. 2024;23:212.

41. Smith L, López Sánchez GF, Soysal P, Tully MA, Koyanagi A. Unclean cooking fuel use and health outcomes in older adults: potential mechanisms, public health implications, and future directions. J Gerontol A Biol Sci Med Sci. 2023;78:2342-7.

42. Miletic M, Sariyar M. Utility-based analysis of statistical approaches and deep learning models for synthetic data generation with focus on correlation structures: algorithm development and validation. JMIR AI. 2025;4:e65729.

43. Su B, Li D, Xie J, et al. Chronic disease in China: geographic and socioeconomic determinants among persons aged 60 and older. J Am Med Dir Assoc. 2023;24:206-212.e5.

44. Chen J, Zhang F, Zhang Y, et al. Trajectories network analysis of chronic diseases among middle-aged and older adults: evidence from the China Health and Retirement Longitudinal Study (CHARLS). BMC Public Health. 2024;24:559.

45. Chen C, Wu H, Yang L, et al. Network analysis of chronic disease among middle-aged and older adults in China: a nationwide survey. Front Public Health. 2025;13:1551034.